Physician
California Retina Associates, LP
California Retina Associates, LP was paid $42.59M by Medicaid between Jan 2018 and Dec 2024, across 47 billing codes. Its largest line is 67028, Intravitreal injection of a pharmacologic agent — 29% of everything it billed.
33Billing provider infoCALIFORNIA RETINA ASSOCIATES, LP
CHULA VISTA, CA 91911
CHULA VISTA, CA 91911
33aNPI1114033404assigned 08/21/2006
33bProvider typeOphthalmology Physician
28Total paid$42.59M
24GClaims707,418
24DCodes billed47
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ophthalmology Physician providers in California
Rank by total paid#1 of 759
Median peer was paid$35K
This provider vs. median1,208×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 96,308 | $5.99M | |
| 2019 | 104,509 | $6.46M | |
| 2020 | 86,191 | $4.93M | |
| 2021 | 102,334 | $6.13M | |
| 2022 | 111,000 | $6.30M | |
| 2023 | 129,916 | $8.12M | |
| 2024incomplete | 77,160 | $4.66M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 67028 | Intravitreal injection of a pharmacologic agent | 29% | 50,841 | 43,583 | $12.55M |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 11% | 8,485 | 7,417 | $4.73M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.6% | 115,186 | 112,676 | $3.24M |
| 92235 | 7.1% | 49,723 | 49,195 | $3.03M | |
| 92250 | 6.8% | 91,836 | 91,174 | $2.88M | |
| 92134 | 6.3% | 109,603 | 108,287 | $2.66M | |
| J9035 | Injection, bevacizumab, 10 mg | 5.6% | 32,275 | 26,992 | $2.40M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.0% | 48,332 | 47,050 | $2.15M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.4% | 21,528 | 21,337 | $1.47M |
| J0178 | Injection, aflibercept, 1 mg | 2.6% | 995 | 916 | $1.12M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 2.3% | 52,886 | 52,547 | $994K |
| 67228 | 2.1% | 3,702 | 3,326 | $904K |
35 more codes
| 92133 | 1.6% | 27,932 | $688K | |
| 15823 | 1.2% | 1,427 | $530K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 1.2% | 25,250 | $491K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.0% | 5,721 | $447K |
| 92083 | 1.0% | 17,961 | $435K | |
| 92136 | <1% | 11,775 | $324K | |
| 68761 | <1% | 4,096 | $314K | |
| 66821 | <1% | 2,633 | $239K | |
| 67210 | <1% | 643 | $194K | |
| 92242 | <1% | 1,410 | $189K | |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | <1% | 124 | $133K |
| J7999 | Compounded drug, not otherwise classified | <1% | 10,037 | $111K |
| 67904 | <1% | 104 | $60K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 1,781 | $52K |
| 92025 | <1% | 1,320 | $33K | |
| 92015 | Determination of refractive state | <1% | 3,270 | $24K |
| 65855 | <1% | 187 | $23K | |
| 65426 | <1% | 53 | $20K | |
| 66982 | <1% | 60 | $19K | |
| 67903 | <1% | 29 | $19K | |
| 67840 | <1% | 134 | $18K | |
| 92020 | <1% | 1,239 | $17K | |
| 92285 | <1% | 1,610 | $14K | |
| 76514 | <1% | 2,161 | $14K | |
| 66761 | <1% | 66 | $13K | |
| J2777 | Injection, faricimab-svoa, 0.1 mg | <1% | 15 | $11K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 401 | $9K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 23 | $5K |
| 76512 | <1% | 82 | $4K | |
| 92002 | <1% | 47 | $1K | |
| 64612 | <1% | 24 | $1K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 353 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 16 | $706.64 |
| 67820 | <1% | 26 | $423.40 | |
| 83861 | <1% | 16 | $105.04 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMANI, NASRIN (OWNER)